Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Medicine and Health Sciences
Stroke In Hfref Without Atrial Fibrillation And Concurrent Protein S Deficiency: What Is The Best Treatment?, Rohan Umrani, Trinava Roy, Bhavana Kadiyala, Yvette Wang
Stroke In Hfref Without Atrial Fibrillation And Concurrent Protein S Deficiency: What Is The Best Treatment?, Rohan Umrani, Trinava Roy, Bhavana Kadiyala, Yvette Wang
Rowan-Virtua Research Day
Hypercoagulable disorders are often the culprit for repeated strokes in young patients, with or without other comorbidities
Medications typically used for stroke prophylaxis:
- Warfarin
- Aspirin
- Direct Oral Anticoagulants (DOACs)
Warfarin is the preferred method of anticoagulation for stroke prophylaxis in patients with hypercoagulable disorders
A deficiency of protein S increases the risk of pro coagulation due to a relative deficiency of anticoagulants.
Patients with protein S deficiency tend to have recurrent venous thromboses and pulmonary emboli